AGTC Genomics and Southern Medical Group bring precision medicine into primary care
Continuing medical education session focuses on how family doctors can identify patients who may benefit from earlier screening, preventive care or specialist referral.

Many people associate precision medicine with expensive genetic tests and specialist treatment in tertiary hospitals. Yet some of its most important opportunities arise much earlier, in the family clinic, while a patient still feels well. A simple question such as “How old was your father when he had his first heart attack?” can change what a doctor looks for and how soon a family receives care.
AGTC Genomics conducted a continuing medical education (CME) session with Southern Medical Group on implementing precision medicine in primary healthcare. The focus was on a decision family doctors face every day: given this patient’s history, symptoms and test results, what can we do now to prevent disease or recognise it earlier?
For cancer prevention, a family history can change when screening begins. A patient who mentions that their mother had bowel cancer at 42 and their aunt had cancer of the womb has given their doctor a reason to explore an inherited condition called Lynch syndrome. The GP can document the pattern and arrange genetic counselling. If Lynch syndrome is confirmed, the patient can begin colonoscopy surveillance earlier, and close relatives can consider targeted testing for the same inherited change.
For cardiovascular disease, a routine cholesterol result can carry a warning for an entire family. Very high LDL cholesterol in someone whose parent had a heart attack at a young age can point to familial hypercholesterolaemia, an inherited cause of high cholesterol. Recognising it in primary care gives the patient an opportunity to start cholesterol-lowering treatment earlier and gives close relatives a reason to have their own cholesterol checked.
For type 2 diabetes, prevention can begin with information already available in the clinic. A family history of diabetes or a history of diabetes during pregnancy can help a GP identify who would benefit from blood glucose testing. If the result shows prediabetes, the patient and doctor can agree on realistic changes to meals and physical activity, then track progress. Structured lifestyle support can delay or prevent progression to type 2 diabetes.
For Alzheimer’s disease, early action begins with taking changes in daily life seriously. When a family reports that someone who once managed household bills easily is now struggling to pay them, a GP can assess cognition, review medicines, look for treatable contributors and arrange specialist evaluation where appropriate. A personalised assessment gives the patient and family a practical next step. Routine genetic screening of healthy adults for Alzheimer’s disease is not recommended.
For a clinic deciding how to introduce precision medicine affordably, a useful starting point is to ask what would change for the patient if a test result were positive or negative. Sometimes the next step is a targeted genetic test. In other cases, it is an earlier colonoscopy, a cholesterol check for a sibling or a follow-up appointment to review blood glucose. Family doctors can connect those decisions over time because they know the patient, often know the family and can follow through on the plan.
Through this CME initiative, AGTC Genomics and Southern Medical Group are bringing precision medicine closer to where most people first seek care. For patients and families, its value lies in leaving an ordinary clinic visit knowing what to do next, why it matters and when to act.
About AGTC Genomics
AGTC Genomics is a Malaysian precision medicine company with BioNexus status. Based in Bukit Jalil, Kuala Lumpur, its advanced genomics laboratory provides testing in hereditary cancer, rare diseases and pharmacogenomics. The laboratory holds accreditation from the College of American Pathologists (CAP), as well as ISO 15189 and ISO/IEC 17025 accreditation.
Through collaborations with healthcare providers and universities, AGTC Genomics helps clinicians identify patients who may benefit from genomic testing, interpret results alongside personal and family history, and explain what those findings mean for patients and their relatives. Its work with primary care teams focuses on decisions that can follow a result, including earlier screening, genetic counselling and specialist referral.




Comments